US FDA advisory panel sets stage for Moderna vaccine authorisation

US FDA advisory panel sets stage for Moderna vaccine authorisation

DNA

Published

The committee voted 20-0 with one abstention that the benefits of the vaccine outweigh its risks in people aged 18 and older.

Full Article